| Original language | English |
|---|---|
| Pages (from-to) | 877-880 |
| Number of pages | 4 |
| Journal | Annals of neurology |
| Volume | 93 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2023 |
Lecanamab Ushers in a New Era of Anti-Amyloid Therapy for Alzheimer's Disease
- Hope Center for Neurological Disorders
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Neurosciences
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Department of Neurology
- DBBS - Molecular Cell Biology
- Center for Brain Immunology & Glia (BIG)
- Intellectual and Developmental Disabilities Research Center (IDDRC)
Research output: Contribution to journal › Review article › peer-review
7
Scopus
citations